| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/28/2004 | CN1491647A Composition for percutaneous treating impotence and female sexual cold and preventing sextual disease |
| 04/28/2004 | CN1491644A Fibrauretine slow releasing prepn |
| 04/28/2004 | CN1147579C Yang-invigorating wine and its preparing process |
| 04/28/2004 | CN1147502C Method for large-scale production of Di (uridine 5'-tetraphosphate) and salts thereof |
| 04/28/2004 | CN1147314C Medicine for treating gynecopathy |
| 04/28/2004 | CN1147301C Progestin therapy with controlled bleeding |
| 04/27/2004 | US6727363 From toluene/diethyl ether mixture; recovering, drying |
| 04/27/2004 | US6727353 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727269 Acromegaly, pituitary adenoma or endocrine gastroenteropanceatic tumors including the carcinoid syndrome, and gastrointestinal bleeding |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727226 Conotoxin peptide extracted from the venom of a marine snail, conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics |
| 04/27/2004 | US6726935 Secreted from venom gland of a toad; formulated as ointment, suspension, gel, spray, patch or solution; for preventing premature, noncontrolled ejaculation and/or sexual hypersensitivity |
| 04/22/2004 | WO2004033461A1 5-SUBSTITUTED 7,9-DIFLUORO-5H-CHROMENO[3,4-f]QUINOLINE COMPOUNDS AS SELECTIVE PROGESTERONE RECEPTOR MODULATORS |
| 04/22/2004 | WO2004018431A3 Novel phenanthridines |
| 04/22/2004 | WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 04/22/2004 | WO2004009784A3 Novel inhibitors of kinases |
| 04/22/2004 | WO2003103770A3 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
| 04/22/2004 | WO2003102012A3 New etonogestrel esters |
| 04/22/2004 | WO2003101958A3 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 04/22/2004 | WO2003078403A3 Derives d’aminoindazoles comme inhibiteurs de proteine-kinase |
| 04/22/2004 | WO2003005999A8 Methods of treating cytokine mediated diseases |
| 04/22/2004 | WO2002090567A3 Sperm-specific cation channel, and uses therefor |
| 04/22/2004 | WO2002074767A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074748A8 Metalloproteinase inhibitors |
| 04/22/2004 | US20040077851 Receptor selective cannabimimetic aminoalkylindoles |
| 04/22/2004 | US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 04/22/2004 | US20040077693 Integrin receptor inhibitors |
| 04/22/2004 | US20040077681 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 04/22/2004 | US20040077678 Urea substituted imidazoquinoline ethers |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | US20040077664 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 04/22/2004 | US20040077649 Novel cannabimimetic ligands |
| 04/22/2004 | US20040077642 Pyrimidine compounds |
| 04/22/2004 | US20040077531 Regulating luteotropic hormone secretion; amino acid sequence 35 |
| 04/22/2004 | US20040077526 SR-BI antagonist and use thereof as contraceptives and in the treatment of steroidal overproduction |
| 04/22/2004 | US20040077523 Using matrix metalloproteinase inhibitor; preventing post-menopausal sagging |
| 04/22/2004 | US20040077007 Human SMN-like protein |
| 04/22/2004 | US20040076692 Mixtures of xanthine oxidase inhibitors and free radical scavangers, used as antiischemic agents or for prophylaxis of cardiovascular disorders |
| 04/22/2004 | US20040074447 Methods of reducing incidence of stillborn pigs by using progesterone receptor antagonists |
| 04/22/2004 | CA2501834A1 5-substituted 7,9-difluoro-5h-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulators |
| 04/21/2004 | EP1410800A1 Use of 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiologically acceptable salts |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409680A2 Novel human proton-gated channels |
| 04/21/2004 | EP1409672A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 04/21/2004 | EP1409645A1 Probiotic lactobacillus salivarius strains |
| 04/21/2004 | EP1409550A1 Extracellular messengers |
| 04/21/2004 | EP1409540A2 Melanocortin receptor ligands |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409526A2 An inducer of apoptosis |
| 04/21/2004 | EP1409525A2 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 04/21/2004 | EP1409513A1 Methylene-4-azasteroids |
| 04/21/2004 | EP1409489A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 04/21/2004 | EP1409455A1 Prostaglandin analogues-as ep4 receptor agonists |
| 04/21/2004 | EP1409007A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1408982A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 04/21/2004 | EP1408950A2 Methods of treating cytokine mediated diseases |
| 04/21/2004 | EP1272481B1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 04/21/2004 | EP1242389B1 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 04/21/2004 | EP1200092B1 Beta-carboline drug products |
| 04/21/2004 | EP1196159B1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 04/21/2004 | EP1109814B1 5-heterocyclyl pyrazolo 4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction |
| 04/21/2004 | EP1049699B1 Pyrazolotriazines as crf antagonists |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1490321A Effective parts of fructus sophorae flavone production and use thereof |
| 04/21/2004 | CN1489996A Diclofenac sodium pastes and preparation thereof |
| 04/21/2004 | CN1146562C Thtraphydrothiopy 2,3-diazanaphthylaone derivatives as PDE4 inhibitors |
| 04/21/2004 | CN1146553C Hydroxymatatairesinol in cancer prevention |
| 04/21/2004 | CN1146445C Materials and methods relating to diagnosis and treatment of pre-eclampsia and diabetes |
| 04/21/2004 | CN1146441C Composition of containing lympha toxin beta receptor |
| 04/20/2004 | US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent |
| 04/20/2004 | US6723725 Indole derivatives |
| 04/20/2004 | US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents |
| 04/20/2004 | US6723715 14, 15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723518 Diagnosing mammary gland pathologies; obtain biopsies, screen for expression of chemokines, presence of chemokine indicates pathology |
| 04/20/2004 | US6723350 Powder of one or more antimicrobial metals formed with atomic disorder; coating becomes antimicrobial and anti-inflammatory when wet. |
| 04/20/2004 | CA2248182C Porcine reproductive and respiratory syndrome vaccine |
| 04/15/2004 | WO2004031180A1 Quinazolin-4-one derivatives |
| 04/15/2004 | WO2004031177A1 2-aminobenzimidazole derivative |
| 04/15/2004 | WO2004031125A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds |
| 04/15/2004 | WO2004030671A2 Use of 4-amino-quinazolines as anti cancer agents |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | WO2004016254A3 Contraceptive methods and formulations |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004004689A8 Compositions and methods for amelioration of human female sexual dysfunction |
| 04/15/2004 | WO2003106381A3 Human adam-10 inhibitors |
| 04/15/2004 | WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/15/2004 | WO2002009690A8 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 04/15/2004 | US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist |
| 04/15/2004 | US20040072891 Urogenital disorders |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072876 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072846 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072818 Antiinflammatory agents; autoimmune disease; anticancer agents |